Steven Aviv

Founder at Pentavere Research Group, Inc.

Technology Services

Profile

Steven Aviv is associated with Pentavere Research Group, Inc. as the Chief Technology Officer since 2016.
He is also the founder of Pentavere Research Group, Inc. which was founded in 2016.

Steven Aviv active positions

Companies	Position	Start
Pentavere Research Group, Inc. Pentavere Research Group, Inc. Information Technology ServicesTechnology Services Pentavere Research Group, Inc. is a Canadian AI digital health company that has developed an AI engine called Darwen™ to identify patients who are eligible for approved medications or interventions. The private company aims to improve patient outcomes and drive therapy growth and penetration. Pentavere's AI system helps identify patients who are eligible for but not receiving approved medications or interventions, thus improving outcomes for patients and driving appropriate therapy growth and penetration. The company also accelerates the discovery of insights and evidence buried in vast amounts of clinical information that is impossible to analyze by human intelligence alone.	Founder	2015-12-31

All active positions of Steven Aviv

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven Aviv's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Pentavere Research Group, Inc. Pentavere Research Group, Inc. Information Technology ServicesTechnology Services Pentavere Research Group, Inc. is a Canadian AI digital health company that has developed an AI engine called Darwen™ to identify patients who are eligible for approved medications or interventions. The private company aims to improve patient outcomes and drive therapy growth and penetration. Pentavere's AI system helps identify patients who are eligible for but not receiving approved medications or interventions, thus improving outcomes for patients and driving appropriate therapy growth and penetration. The company also accelerates the discovery of insights and evidence buried in vast amounts of clinical information that is impossible to analyze by human intelligence alone.	Technology Services